State Of Wisconsin Investment Board Assembly Biosciences, Inc. Transaction History

State Of Wisconsin Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$4.87 - $17.29 $337,978 - $1.2 Million	-69,400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$15.08 - $27.04 $357,396 - $640,848	23,700 Added 51.86%	69,400 $1.14 Million
Q2 2020 Aug 12, 2020	BUY	$14.57 - $23.96 $26,226 - $43,128	1,800 Added 4.1%	45,700 $1.07 Million
Q1 2020 May 06, 2020	BUY	$10.27 - $21.23 $101,673 - $210,177	9,900 Added 29.12%	43,900 $651,000
Q3 2019 Nov 12, 2019	SELL	$9.83 - $14.82 $291,803 - $439,931	-29,685 Reduced 46.61%	34,000 $334,000
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $179,116 - $288,808	13,885 Added 27.88%	63,685 $859,000
Q1 2019 May 13, 2019	BUY	$17.7 - $24.93 $115,050 - $162,045	6,500 Added 15.01%	49,800 $981,000
Q4 2018 Feb 11, 2019	BUY	$19.05 - $36.45 $85,725 - $164,025	4,500 Added 11.6%	43,300 $979,000
Q3 2018 Nov 14, 2018	BUY	$34.41 - $44.23 $739,814 - $950,944	21,500 Added 124.28%	38,800 $1.44 Million
Q2 2018 Aug 03, 2018	BUY	$39.21 - $50.29 $247,023 - $316,827	6,300 Added 57.27%	17,300 $678,000
Q3 2017 Nov 01, 2017	BUY	$23.08 - $34.92 $253,879 - $384,120	11,000	11,000 $384,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.